A股異動 | 雷科防務(002413.SZ)漲7.8% 擬成立合資公司受讓華鋒股份5.09%股份
格隆匯8月3日丨雷科防務(002413.SZ)現報10.16元,漲幅7.86%,最新總市值112億,換手率11.78%。公司公告稱,全資子公司理工雷科擬與自然人陳欽城共同發起設立北京雷科卓碩科技中心(有限合夥)。雷科卓碩擬以協議轉讓方式受讓華鋒股份896.49萬股,佔華鋒股份總股本的5.09%,代價9861.39萬元。華鋒股份主要從事電解電容器原材料腐蝕賦能鋁箔及元器件專用材料、電子元器件產品、高效聚合氯化鋁鐵淨水劑及高效脱色劑、污水處理劑產品的開發、生產、銷售和進出口業務。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.